DrugsControl Media Services
DrugsControl.org

News Detail

Covid-19: IAVI, Merck, Serum join hands to develop monoclonal antibodies (23-10-2020)

Pune, 22 Oct 2020: IAVI, a non-profit scientific research organisation dedicated to addressing urgent and unmet global health challenges, and Pune-based Serum Institute of India Pvt Ltd, have announced an agreement with Merck to develop SARS-CoV-2-neutralising monoclonal antibodi......
View Details

Source : The Hindu Businessline

Related News